| 2026-08-11 | 10-Q | 10.1 | AMENDMENT NO. 1 TO THE COMPANY'S 2024 EQUITY INCENTIVE PLAN, AS AMENDED |
|---|
| 2026-05-13 | 10-Q | 10.1 | NON-EMPLOYEE DIRECTOR COMPENSATION POLICY |
|---|
| 2026-03-10 | 10-K | 10.4 | SECOND AMENDMENT TO SUBSCRIPTION AGREEMENT, DATED DECEMBER 17, 2025, BY AND AMONG THE REGISTRANT AND THE INSTITUTIONAL INVESTORS NAMED THEREIN |
|---|
| 2025-08-11 | 10-Q | 10.3 | 2024 EQUITY INCENTIVE PLAN, AS AMENDED |
|---|
| 2025-08-11 | 10-Q | 10.2 | EXECUTIVE EMPLOYMENT AGREEMENT, EFFECTIVE AS OF JUNE 2, 2025, BY AND BETWEEN THE REGISTRANT AND WILLIAM CONKLING |
|---|
| 2025-05-08 | 10-Q | 10.7 | NON-EMPLOYEE DIRECTOR COMPENSATION POLICY |
|---|
| 2025-05-08 | 10-Q | 10.6 | EXECUTIVE EMPLOYMENT AGREEMENT, EFFECTIVE AS OF APRIL 15, 2025, BY AND BETWEEN THE REGISTRANT AND LEONARDO NICACIO, M.D |
|---|
| 2025-03-05 | 10-K | 10.36 | FIRST CERTIFICATE OF AMENDMENT TO INDUCEMENT PLAN OF THE REGISTRANT DATED MARCH 3, 2025 |
|---|
| 2024-05-02 | 10-Q | 10.2 | RETENTION BONUS, EFFECTIVE AS OF JANUARY 25, 2024, BY AND BETWEEN REGISTRANT AND JACQUELINE ZUMMO, PH.D, MPH, MBA |
|---|
| 2024-05-02 | 10-Q | 10.1 | AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY |
|---|
| 2024-04-05 | 8-K | 10.4 | REGISTRATION RIGHTS AGREEMENT, DATED APRIL 5, 2024 |
|---|
| 2024-04-05 | 8-K | 10.3 | FORM OF COMMON STOCK PURCHASE WARRANT |
|---|
| 2024-04-05 | 8-K | 10.2 | FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT |
|---|
| 2024-04-05 | 8-K | 10.1 | SUBSCRIPTION AGREEMENT, DATED APRIL 5, 2024 |
|---|
| 2024-03-18 | 8-K | 10.1 | SEPARATION AND CONSULTING AGREEMENT AND RELEASE, DATED AS OF MARCH 18, 2024, BY AND BETWEEN THE COMPANY AND JATHIN BANDARI |
|---|
| 2023-08-03 | 10-Q | 10.1 | AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT, ENTERED INTO AS OF JUNE 1, 2023, BY AND BETWEEN THE REGISTRANT AND PATRICK FABBIO |
|---|
| 2023-03-08 | 10-K | 10.17 | EXECUTIVE EMPLOYMENT AGREEMENT, EFFECTIVE AS OF JANUARY 30, 2023 BY AND BETWEEN THE REGISTRANT AND PATRICK FABBIO |
|---|
| 2022-06-21 | 8-K | 10.1 | SEPARATION AGREEMENT AND RELEASE, DATED AS OF JUNE 20, 2022, BY AND BETWEEN BLAINE DAVIS AND THE COMPANY |
|---|
| 2022-05-05 | 10-Q | 10.2 | EXECUTIVE EMPLOYMENT AGREEMENT, EFFECTIVE AS OF JANUARY 10, 2022, BY AND BETWEEN THE REGISTRANT AND JATHIN BANDARI, M.D. |
|---|
| 2022-05-05 | 10-Q | 10.1 | AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY |
|---|
| 2021-10-18 | 8-K | 10.2 | SEPARATION AGREEMENT AND RELEASE, DATED AS OF OCTOBER 15, 2021, BY AND BETWEEN THE COMPANY |
|---|
| 2021-10-18 | 8-K | 10.1 | CONSULTING AGREEMENT, DATED AS OF OCTOBER 16, 2021, BY AND BETWEEN THE COMPANY |
|---|
| 2021-05-06 | 10-Q | 10.2 | EXECUTIVE EMPLOYMENT AGREEMENT, EFFECTIVE AS OF APRIL 19, 2021 BY AND BETWEEN THE REGISTRANT AND MARTIN SEBASTIAN OLIVO, M.D |
|---|
| 2021-05-06 | 10-Q | 10.1 | RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY |
|---|
| 2021-03-11 | 10-K | 10.25 | LEASE BY AND BETWEEN 345 PAS HOLDING LLC, AND THE REGISTRANT, DATED AS OF DECEMBER 7, 2020 |
|---|
| 2020-11-12 | 10-Q | 10.1 | AMENDMENT TO AGREEMENT, BY AND BETWEEN CHUGAI PHARMACEUTICAL CO., LTD. AND THE REGISTRANT, DATED AS OF JULY 14, 2020 AND EFFECTIVE AS OF JUNE 30, 2020 |
|---|
| 2020-07-31 | 10-Q | 10.2 | SEPARATION AGREEMENT AND RELEASE, DATED AS OF JULY 23, 2020, BY AND BETWEEN THE REGISTRANT AND JULIO CASOY |
|---|
| 2020-07-31 | 10-Q | 10.1 | RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY |
|---|
| 2020-03-30 | 8-K | 10.3 | FORMS OF RESTRICTED STOCK UNIT GRANT NOTICE AND RESTRICTED STOCK UNIT AGREEMENT UNDER ARTARA THERAPEUTICS, INC. INDUCEMENT PLAN |
|---|
| 2020-03-30 | 8-K | 10.2 | FORM OF STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT UNDER ARTARA THERAPEUTICS, INC. INDUCEMENT PLAN |
|---|
| 2020-03-30 | 8-K | 10.1 | ARTARA THERAPEUTICS, INC. INDUCEMENT PLAN |
|---|
| 2020-03-20 | 10-K | 10.36 | Restated Non-Employee Director Compensation Policy. |
|---|
| 2020-03-20 | 10-K | 10.30 | Executive Employment Agreement, effective as of February 11, 2020 by and between the Registrant and Blaine Davis. |
|---|
| 2020-03-20 | 10-K | 10.29 | Executive Employment Agreement, dated as of February 6, 2020, by and between the Registrant and Julio Casoy, M.D. |
|---|
| 2020-03-20 | 10-K | 10.25 | Forms of Stock Option Agreement, Option Exercise, Restricted Stock Unit Grant and Restricted Stock Unit Agreement under the Amended and Restated 2014 Equity Incentive Plan of the Registrant, as amended. |
|---|
| 2020-01-10 | 8-K | 10.11 | 2017 Equity Incentive Plan of ArTara Subsidiary, Inc. |
|---|
| 2020-01-10 | 8-K | 10.10 | Non-Employee Director Compensation Policy. |
|---|
| 2020-01-10 | 8-K | 10.9 | Subscription Agreement, dated September 23, 2019, by and among the Registrant and the institutional investors named therein, and the First Amendment to Subscription Agreement, dated November 19, 2019, by and among the Registrant, ArTara Subsidiary, Inc. and the institutional investors named therein. |
|---|
| 2020-01-10 | 8-K | 10.8 | Form of Indemnity Agreement between the Registrant and each of its directors and officers. |
|---|
| 2020-01-10 | 8-K | 10.7 | Agreement, by and between ArTara Subsidiary, Inc. and Chugai Pharmaceutical Co., Ltd. dated as of June 17, 2019. |
|---|
| 2020-01-10 | 8-K | 10.6 | License Agreement, by and between ArTara Subsidiary, Inc. and The Feinstein Institute for Medical Research dated as of December 22, 2017. |
|---|
| 2020-01-10 | 8-K | 10.5 | Sponsored Research and License Agreement, by and between ArTara Subsidiary, Inc. and The University of Iowa dated as of November 28, 2018. |
|---|
| 2020-01-10 | 8-K | 10.4 | Choline License Agreement, by and between ArTara Subsidiary, Inc. and Alan L. Buchman, M.D. dated as of September 27, 2017. |
|---|
| 2020-01-10 | 8-K | 10.3 | Executive Employment Agreement, dated as of December 17, 2019, by and between ArTara Subsidiary, Inc. and Jacqueline Zummo, Ph.D., MPH, MBA. |
|---|
| 2020-01-10 | 8-K | 10.2 | Executive Employment Agreement, dated as of November 5, 2019, as amended on December 4, 2019, by and between ArTara Subsidiary, Inc. and Jesse Shefferman. |
|---|
| 2020-01-10 | 8-K | 10.1 | Amended and Restated 2014 Equity Incentive Plan of the Registrant, as amended. |
|---|
| 2019-12-23 | 8-K | 10.1 | Separation Agreement, dated December 20, 2019, by and between Proteon Therapeutics, Inc. and George A. Eldridge |
|---|
| 2019-10-02 | 8-K | 10.2 | Consulting Agreement, dated October 1, 2019, by and among Proteon Therapeutics, Inc., certain of Proteon’s subsidiaries and Timothy P. Noyes |
|---|
| 2019-10-02 | 8-K | 10.1 | Separation Agreement, dated September 30, 2019, by and between Proteon Therapeutics, Inc. and Timothy P. Noyes |
|---|
| 2019-09-24 | 8-K | 10.5 | Registration Rights Agreement, dated September 23, 2019, by and among Proteon Therapeutics, Inc. and the institutional investors named therein. |
|---|
| 2019-09-24 | 8-K | 10.4 | Subscription Agreement, dated September 23, 2019, by and among Proteon Therapeutics, Inc. and the institutional investors named therein. |
|---|
| 2019-09-24 | 8-K | 10.3 | Form of Lock-Up Agreement, by each of the parties named in each agreement therein. |
|---|
| 2019-09-24 | 8-K | 10.2 | Form of Support Agreement, by and among Proteon Therapeutics, Inc., ArTara Therapeutics, Inc. and certain stockholders of Proteon Therapeutics, Inc. named therein. |
|---|
| 2019-09-24 | 8-K | 10.1 | Form of Support Agreement, by and among ArTara Therapeutics, Inc., Proteon Therapeutics, Inc. and certain stockholders of ArTara Therapeutics, Inc. named therein. |
|---|
| 2018-08-07 | 10-Q | 10.1 | Amendment No. 3 to Manufacturing Services Agreement by and between the Company and Lonza LTD dated as of May 4, 2018. |
|---|
| 2017-11-07 | 10-Q | 10.2 | Fourth Amendment to Lease by and between Proteon Therapeutics, Inc. and Boston Properties Limited Partnership, dated August 17, 2009. |
|---|
| 2017-08-03 | 8-K | 10.1 | EXHBIT 10.1 |
|---|
| 2017-06-23 | 8-K | 10.20 | Securities Purchase Agreement, dated June 22, 2017, by and among Proteon Therapeutics, Inc. and the Investors party thereto. |
|---|
| 2017-03-16 | 10-K | 10.19 | Re: Amendment No. 1 to Employment Agreement |
|---|
| 2016-05-09 | 10-Q | 10.1 | AMENDMENT NO. 2 |
|---|
| 2015-11-12 | 8-K | 10.1 | Sales Agreement dated November 12, 2015 by and between Proteon Therapeutics, Inc. and Cowen and Company, LLC |
|---|
| 2015-11-12 | 10-Q | 10.1 | Manufacturing Services Agreement by and between the Company and Lonza LTD, dated as of June 30, 2015 and signed July 9, 2015. |
|---|